Lactose (India) Ltd | 151 Cr. | 120 | 247/84.3 | 34.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,478 Cr. | 412 | 434/192 | 100 | 22.8 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 42.0 Cr. | 56.6 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 32.4 Cr. | 22.1 | 29.1/17.0 | 33.7 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 60.6 Cr. | 80.4 | 142/78.9 | 16.0 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 53,890 Cr. | 1,910 | 2,286/1,275 | 40.4 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 276 Cr. | 12.1 | 23.8/10.8 | 16.8 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 709 Cr. | 1,502 | 1,502/635 | 30.2 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 103 Cr. | 20.7 | 32.0/15.0 | 31.6 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 869 Cr. | 295 | 449/219 | 8.31 | 123 | 0.85 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 12.1 Cr. | 4.85 | 9.28/2.11 | 6.86 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 395 Cr. | 407 | 477/112 | 63.6 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,900 Cr. | 1,124 | 1,584/1,045 | 47.8 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 73.6 Cr. | 0.36 | 1.24/0.36 | 4.84 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 58.0 Cr. | 24.1 | 26.3/6.40 | 59.7 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.0 Cr. | 9.94 | 17.3/9.50 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 184 Cr. | 516 | 961/443 | 9.98 | 563 | 0.29 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 66.5 Cr. | 66.5 | 71.2/26.1 | 171 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 18.3 Cr. | 40.1 | 88.7/37.9 | 38.2 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 13.8 Cr. | 5.54 | 5.54/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.4 Cr. | 116 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 31.3 Cr. | 57.2 | 57.2/9.41 | 347 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 32.4 Cr. | 43.0 | 80.0/0.00 | 45.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.48 Cr. | 21.6 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,528 Cr. | 664 | 1,028/464 | 32.2 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 90.2 Cr. | 20.9 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.4 Cr. | 22.5 | 43.7/17.4 | 49.6 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 280 Cr. | 486 | 524/241 | 29.3 | 119 | 0.93 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 62.2 Cr. | 43.4 | 62.6/31.6 | 56.1 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 66,592 Cr. | 1,137 | 1,503/994 | 19.6 | 557 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 136 Cr. | 218 | 303/170 | 197 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 802 Cr. | 80.2 | 123/74.0 | 17.4 | 32.5 | 1.87 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 42.8 Cr. | 32.8 | 51.3/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 12,269 Cr. | 1,498 | 1,530/727 | 64.9 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.16 Cr. | 0.63 | 1.45/0.63 | 83.3 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 261 Cr. | 34.1 | 68.0/30.0 | 13.9 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.48 Cr. | 16.2 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 143 Cr. | 6.05 | 6.57/2.82 | 259 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 63,643 Cr. | 29,995 | 37,000/25,260 | 43.8 | 1,992 | 1.58 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,466 Cr. | 825 | 972/550 | 28.0 | 220 | 0.61 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 245 Cr. | 83.5 | 84.0/31.3 | 59.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,419 Cr. | 1,458 | 1,577/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 22,547 Cr. | 1,388 | 1,870/1,006 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 819 Cr. | 249 | 330/154 | 19.1 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 602 Cr. | 451 | 568/270 | 12.9 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,376 Cr. | 479 | 950/456 | 27.0 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,613 Cr. | 1,143 | 1,755/991 | 23.9 | 754 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,18,922 Cr. | 3,518 | 3,790/2,886 | 58.9 | 224 | 0.91 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,174 Cr. | 128 | 317/98.0 | | 43.7 | 0.39 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,564 Cr. | 16.6 | 24.0/14.1 | 27.5 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 33,871 Cr. | 885 | 1,360/856 | 96.3 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,584 Cr. | 201 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,00,317 Cr. | 1,668 | 1,925/1,547 | 34.9 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,653 Cr. | 595 | 886/441 | 108 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,484 Cr. | 280 | 354/175 | 35.4 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 340 Cr. | 1,125 | 1,690/956 | 19.7 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 7,143 Cr. | 365 | 502/265 | 55.6 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,449 Cr. | 216 | 232/111 | 181 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,834 Cr. | 4,704 | 7,090/4,146 | 30.4 | 340 | 2.49 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,799 Cr. | 2,297 | 2,977/1,772 | 36.7 | 321 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,156 Cr. | 6,118 | 6,739/4,863 | 33.8 | 323 | 2.04 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 151 Cr. | 42.9 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,296 Cr. | 5,530 | 6,020/3,701 | 37.4 | 922 | 0.63 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 348/81.0 | 8.88 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,696 Cr. | 440 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,694 Cr. | 728 | 1,998/604 | 43.4 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,932 Cr. | 16,315 | 18,100/10,060 | 159 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 311 Cr. | 13.9 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,042 Cr. | 840 | 1,505/660 | 8.86 | 425 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,682 Cr. | 49.0 | 94.5/41.7 | 29.0 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,062 Cr. | 178 | 359/162 | 23.0 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 110 Cr. | 69.3 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 351 Cr. | 98.4 | 177/90.2 | 46.8 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 90,091 Cr. | 1,972 | 2,403/1,774 | 24.4 | 377 | 0.61 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,050 Cr. | 524 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 47,197 Cr. | 874 | 944/440 | 92.6 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 895 Cr. | 863 | 1,235/596 | 20.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 154 Cr. | 71.4 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 826 Cr. | 171 | 329/154 | 23.6 | 107 | 1.75 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 625 Cr. | 357 | 500/265 | 22.3 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,483 Cr. | 1,098 | 1,310/802 | 36.0 | 393 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,998 Cr. | 1,660 | 1,998/1,303 | 38.0 | 221 | 0.93 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,445 Cr. | 217 | 328/175 | 33.9 | 36.1 | 1.15 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,578 Cr. | 1,324 | 1,758/1,168 | 37.5 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,929 Cr. | 99.8 | 127/57.5 | 27.8 | 57.5 | 0.80 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 791 Cr. | 108 | 134/67.2 | 35.9 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
Indoco Remedies Ltd | 2,738 Cr. | 297 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 2,957 Cr. | 240 | 465/239 | 46.7 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,443 Cr. | 1,696 | 2,786/1,243 | 38.4 | 369 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,662 Cr. | 365 | 504/285 | 59.9 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
Granules India Ltd | 13,687 Cr. | 564 | 628/412 | 28.7 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 53,889 Cr. | 1,910 | 2,286/1,275 | 40.4 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,595 Cr. | 2,750 | 3,516/1,921 | 49.2 | 115 | 1.53 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,775 Cr. | 1,929 | 2,131/1,200 | 28.0 | 592 | 0.93 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,261 Cr. | 446 | 570/359 | 27.0 | 140 | 1.12 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,932 Cr. | 1,610 | 1,910/1,097 | 56.6 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,362 Cr. | 1,262 | 1,406/1,020 | 18.6 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,585 Cr. | 292 | 322/169 | 38.6 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,26,302 Cr. | 1,564 | 1,612/1,310 | 23.4 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,262 Cr. | 2,008 | 2,641/1,551 | 27.0 | 375 | 0.30 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 377 Cr. | 128 | 203/95.6 | 186 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,635 Cr. | 155 | 191/105 | 15.3 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 66.6 Cr. | 41.0 | 78.0/40.0 | 23.9 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 46,714 Cr. | 349 | 406/291 | 129 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,736 Cr. | 1,720 | 2,215/1,430 | 37.9 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 131 Cr. | 82.1 | 141/76.3 | 18.3 | 48.6 | 1.46 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 369 Cr. | 156 | 179/67.8 | 36.6 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 23,056 Cr. | 9,222 | 10,691/6,220 | 109 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,036 Cr. | 704 | 843/544 | 37.3 | 113 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 187 Cr. | 89.0 | 137/85.0 | 7.11 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,671 Cr. | 5,492 | 6,319/4,492 | 28.9 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,550 Cr. | 944 | 1,202/725 | 31.3 | 264 | 1.17 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 455 Cr. | 796 | 1,540/763 | 72.3 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,222 Cr. | 2,419 | 3,395/2,022 | 32.5 | 303 | 1.16 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,487 Cr. | 312 | 518/258 | 25.5 | 127 | 1.67 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,707 Cr. | 512 | 575/312 | 26.3 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,002.99 Cr | 1,173.73 | | 50.07 | 192.71 | 0.33% | 16.15% | 14.90% | 6.18 |